Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) saw a large growth in short interest in June. As of June 15th, there was short interest totaling 51,245 shares, a growth of 81.6% from the May 31st total of 28,220 shares. Based on an average daily volume of 46,880 shares, the short-interest ratio is presently 1.1 days. Currently, 2.2% of the shares of the stock are sold short.
Institutional Trading of Innovator IBD 50 ETF
Several large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets acquired a new stake in Innovator IBD 50 ETF during the third quarter worth approximately $1,494,000. Royal Bank of Canada boosted its stake in Innovator IBD 50 ETF by 3,222.5% in the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after buying an additional 17,724 shares in the last quarter. Prosperity Wealth Management Inc. acquired a new stake in shares of Innovator IBD 50 ETF in the 3rd quarter valued at approximately $637,000. HRT Financial LP bought a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $507,000. Finally, JPMorgan Chase & Co. bought a new stake in Innovator IBD 50 ETF during the 3rd quarter worth $478,000.
Innovator IBD 50 ETF Trading Down 4.2%
Shares of Innovator IBD 50 ETF stock opened at $40.66 on Friday. The stock has a market capitalization of $87.42 million, a price-to-earnings ratio of 30.34 and a beta of 1.45. Innovator IBD 50 ETF has a 1-year low of $31.42 and a 1-year high of $44.08. The firm’s 50-day moving average price is $40.66 and its two-hundred day moving average price is $38.03.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
